Consideration of postpartum management in HIV-positive haitian women: An analysis of CD4 decline, mortality, and follow-up after delivery

Journal of Acquired Immune Deficiency Syndromes

Volumn 61, Issue 5, 2012, Pages 636-643

  Coria, Alexandra ^a   Noel, Francine ^b   Bonhomme, Jerry ^b   Rouzier, Vanessa ^b   Perodin, Christian ^b   Marcelin, Adias ^b   Li, Zhongze ^c   Tosteson, Tor D ^c   Deschamps, Marie Marcelle ^b   Wright, Peter F ^a   Pape, Jean W ^b,d  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Department of Adolescent Medicine   (Haïti)

^c NORRIS COTTON CANCER CENTER   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

HAART; Haiti; PMTCT

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; BIRTH RATE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DELIVERY; DETERIORATION; FEMALE; FOLLOW UP; HAITI; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MEDICAL RECORD; OUTCOME ASSESSMENT; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; RETROSPECTIVE STUDY; YOUNG ADULT; ARTICLE; DISEASE COURSE; IMMUNOLOGY; KAPLAN MEIER METHOD; MALE; MORTALITY; NEWBORN; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATION; TIME;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HAITI; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; MALE; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84873114094     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31826abdd1     Document Type: Conference Paper

References (25)

1. UNAIDS. 2008 Report on the global AIDS epidemic. 2008. Available at: http://www.unaids.org/en/dataanalysis/epidemiology/2008reportonthegloba- laidsepidemic/. Accessed August 23, 2012.
2. UNAIDS. Epidemiological fact sheets on HIV and AIDS. 2008. Available at: http://158.232.15.29/CFS/downloadpdf.htm?country-id=LACHTI&lng-code= en&pdfoption=epi. 2008 Update. Accessed August 23, 2012.
3. Cayemittes M, Placide F, Barrère B, et al Enqûete Mortalité, Morbidité, et Utilisation des Services EMMUS-IV 2005-2006. 2006. Available at: http://www.measuredhs.com/pubs/pdf/fr192/fr192. pdf. Accessed August 23, 2012.
4. Ministère de la Santé Publique et de la Population, Institut Haïtien de l'Enfance, Centres GHESKIO, et al. Etude de séro surveillance par méthode sentinelle de la prévalence du VIH, de la syphilis, de l'hépatite B et de l'hépatite C et chez les femmes enceintes en Haïti 2006/2007. 2007. Available at: http://data.unaids.org/ pub/Report/2007/haitihivserosurveill2007-fr. pdf. Accessed August 23, 2012.
5. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: toward universal access: recommendations for a public health approach-2006 version. 2006. Available at: http://www.who.int/hiv/pub/guidelines/pmtctguidelines3.pdf. Accessed August 23, 2012.
6. World Health Organization. Rapid advice: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2009. Available at: http://www.who.int/hiv/pub/arv/rapid-advice-art.pdf. Accessed August 23, 2012.
7. Noel F, Mehta S, Zhu Y., et al Improving outcomes in infants of HIV-infected women in a developing country setting. PLoS One. 2008;3:e3723.
8. Deschamps M, Noel F, Bonhomme J., et al Prevention of mother-to-child transmission of HIV in Haiti. Rev Panam Salud Pública. 2009;25:24-30.
9. Severe P, Juste MAJ, Ambroise A, et al Early versus standard antire-troviral therapy for HIV-infected adults in Haiti. N Engl J Med. 2010; 363:257-265.
10. Emery S, Neuhaus JA, Phillips A.N., et al Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008;197:1133-1144.
11. Kitahata MM, Gange SJ, Abraham A.G., et al Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360:1815-1826. Available at: http://content.nejm.org. Accessed August 23, 2012.
12. Sterne JA, May M, et al When to Start Consortium. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373:1352-1363. Available at: http://www.sciencedirect.com/science/article/B6T1B-4W1F67B-1/2/ ff5a377934d7893f449015512fc1e517. Accessed August 23, 2012.
13. Kranzer K, Zeinecker J, Ginsberg P., et al Linkage to HIV care and anti-retroviral therapy in Cape Town, South Africa. PLoS One. 2010;5:e13801.
14. Larson BA, Brennan A, McNamara L., et al Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bull World Health Organ. 2010;88:675-680.
15. Tayler-Smith K., Zachariah R, Massaquoi M., et al Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system? Trans R Soc Trop Med Hyg. 2010;104:313-319.
16. Leger P, Charles M, Severe P., et al 5-year survival of patients with AIDS receiving antiretroviral therapy in Haiti. N Engl J Med. 2009; 361:828-829. Available at: http://content.nejm.org. Accessed August 23, 2012.
17. Kesho Bora Study Group. Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts. J Acquir Immune Defic Syndr. 2010;54:533-541.
18. Marazzi MC, Nielsen-Saines K, Buonomo E., et al Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding. Pediatr Infect Dis J. 2009;28:483-487.
19. Mofenson LM. Protecting the next generation-eliminating perinatal HIV-1 infection. N Engl J Med. 2010;362:2316-2318.
20. Palombi L, Marazzi MC, Voetberg A, et al Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS. 2007;21(suppl 4):S65-S71.
21. Peltier CA, Ndayisaba GF, Lepage P, et al Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS. 2009;23:2415-2423.
22. Shapiro RL, Hughes MD, Ogwu A, et al Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362: 2282-2294.
23. Taha T, Kumwenda J, Cole S., et al Postnatal HIV?1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. J Infect Dis. 2009;200: 1490-1497.
24. World Health Organization. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2012. Available at: http://www.who.int/hiv/PMTCT-update.pdf. Accessed August 23, 2012.
25. Montaner JSG, Lima VD, Barrios R, et al Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376:532-539.